Porton Shares: Summary table of non-operating fund occupation and other related fund transactions in 2025
Summary table of non-operating fund occupation and other related fund transactions
2025
Compilation unit: Chongqing Boteng Pharmaceutical Technology Co., Ltd. Unit: RMB 10,000 Total funds occupied in 2025 Total funds occupied in 2025
Occupier and listed company Listed company’s calculation: Beginning of 2025 Accumulated repayment in 2025 End of 2025
Occupation of non-operating funds Name of the party who occupies the funds Interest on the amount incurred Reasons for the occupation Related relationships of the nature of the occupation Accounting items Balance of funds occupied Amount incurred Balance of funds occupied
(excluding interest) (if any)
Controlling shareholders, actual controllers and their affiliated companies
small plan
Former controlling shareholders, actual controllers and their affiliated companies
small plan
Other related parties and their subsidiaries
small plan
total
Total current funds in 2025 Current funds in 2025
The counterparty and the listed company. The listed company calculated the accumulated repayment in 2025 at the beginning of 2025. The nature of the transaction at the end of 2025 (operating fund transactions with other related parties. Name of the fund counterparty. Amount incurred. Reasons for the transaction.
Related relationships Accounting items Current fund balance Occurrence amount Current fund balance (current, non-operating transactions)
(excluding interest) (if any)
Controlling shareholders, actual controllers and their affiliated companies
Porton Hong Kong Co., Ltd. Wholly-owned subsidiary Other receivables 9,718.85 17,119.91 26,838.76 Provision of funds, etc. Non-operating transactions Porton Meiyan Co., Ltd. Wholly-owned subsidiary Other receivables 85.74 430.30 516.04 Provision of funds, etc. Non-operating transactions Shanghai Porten Zhituo Pharmaceutical Technology Co., Ltd. Wholly-owned subsidiary Other receivables 8,066.01 11,240.07 10,274.55 9,031.53 Providing funds, etc. Non-operating transactions Shanghai Boteng Zhihui Biopharmaceutical Co., Ltd. Wholly-owned subsidiary Other receivables 8,159.77 2,627.47 4,200.72 6,586.52 Providing funds, etc. Non-operating transactions with Shanghai Tengzhuo Pharmaceutical Co., Ltd. Wholly-owned subsidiary Other receivables 1,357.15 1,357.15 Providing funds, etc. Non-operating transactions with Shanghai Feiteng Pharmaceutical Technology Co., Ltd. Wholly-owned subsidiary Other receivables 18,268.97 11,314.19 10,818.67 18,764.49 Providing funds, etc. Non-operating transactions Porton Zhixin (Shanghai) Biotechnology Co., Ltd. Wholly-owned subsidiary Other receivables 20.00 20.00 Provision of funds, etc. Non-operating transactions Subsidiaries and affiliates of listed companies Jiangxi Porton Pharmaceutical Co., Ltd. Wholly-owned subsidiary Other receivables 4,454.36 13,806.42 18,260.78 Provision of funds, etc. Non-operating transactions Hubei Yuyang Pharmaceutical Co., Ltd. Wholly-owned subsidiaries Other receivables 4,364.98 6,040.91 1,706.49 8,699.40 Provision of funds, etc. Non-operating transactions Suzhou Poten Biopharmaceutical Co., Ltd. Holding subsidiary Other receivables 191.39 162.57 33.69 320.27 Provision of funds, etc. Non-operating transactions Chongqing Bonian Biotechnology Co., Ltd. Wholly-owned subsidiary Other receivables 2.70 0.10 2.80 Providing funds, etc. Non-operating transactions Chongqing Boxing Pharmaceutical Chemical Co., Ltd. Wholly-owned subsidiary Other receivables 300.00 700.00 700.00 300.00 Providing funds, etc. Non-operating transactions Chongqing Boteng Zhiyun Technology Co., Ltd. Wholly-owned subsidiary Other receivables 4,540.48 1,466.12 1,800.00 4,206.60 Providing funds, etc. Non-operating transactions with Chongqing Boteng Biomedical Research Institute Co., Ltd. Wholly-owned subsidiary Other receivables 0.10 0.10 Providing funds, etc. Non-operating transactions with Chongqing Boteng Pharmaceutical Co., Ltd. Wholly-owned subsidiary Other receivables 3,847.62 17,909.47 21,757.09 Provision of funds, etc. Non-operating transactions
Other related parties and their subsidiaries
Total 63,378.02 82,655.06 162.57 75,990.81 70,204.84
Legal representative: Ju Nianfeng Person in charge of accounting work: Chen Hui Head of accounting department: Ruan Yaqian